| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |